Drug profile · INN
gabapentin enacarbil
HORIZANT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
gabapentin enacarbil (HORIZANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN gabapentin enacarbil
Brand HORIZANT
Route ORAL
Formulation TABLET, EXTENDED RELEASE
Frequently asked questions
What is gabapentin enacarbil?
gabapentin enacarbil (HORIZANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for gabapentin enacarbil?
HORIZANT is a marketed brand name for gabapentin enacarbil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gabapentin enacarbil?
gabapentin enacarbil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.